Dr. Peter Powchik was the Senior Vice President of Clinical Development at Regeneron, where he built an international clinical drug development organization and oversaw the company’s first five drug approvals. Earlier in his career, Peter was Chief Medical Officer of Chugai Pharma USA and held senior development positions with Novartis Pharmaceuticals Corp., Sepracor Inc. and Pfizer Inc. In addition, Peter was a faculty member at the Mount Sinai School of Medicine in New York City. He earned his M.D. degree from the New York University School of Medicine and a B.A. in chemistry, with honors, from SUNY College at Purchase.